The independent source for health policy research, polling, and news.
2,961-2,980 of 113,008 results
The findings, which will be presented this week at the International Society for Autism Research, show that only mild autism cases rose between 2000 and 2016. Meanwhile, the White House has so far declined to include key autism advocacy groups and researchers in its efforts to address autism.
Diabetes deaths peaked in 2021 at the height of the covid pandemic, but they've been trending down. Although levels are still higher than before the start of covid, they are the lowest they have been in years, preliminary data show. Simultaneously, breast cancer deaths among young women fell between 2010 and 2020.
A Republican effort to overturn Amendment 3 — which voters approved in November with 51.6% of the vote — advanced Wednesday, St. Louis Public Radio reported.
Financially struggling Catalina Island Health faces insolvency as early as July. In other news from California: today's UC health worker strike; a probe into health data sharing with LinkedIn; the soda tax in Santa Cruz; and more.
A group of state lawmakers pressed the attorney general to launch an investigation for the shuttering of Crozer Health by California-based private health company Prospect Medical Holdings. Envision Healthcare, Teladoc, Two Chairs, Epic, CareFirst BlueCross BlueShield, and the Leapfrog Group are also in the news.
The Trump administration's decision to end federal participation in the Safe to Sleep campaign comes as recent data show sudden infant deaths rising. Also: Education Department grant cuts, animals in federally funded research, PEPFAR cut impacts, and more.
Public health experts worry the policy change would not only cast doubt on the safety and effectiveness of vaccines but would limit production and access. Separately, a decades-long pursuit of universal vaccines gets a $500 million boost.
Today's early morning highlights from the major news organizations.
Editorial writers discuss the following public health topics.
The bill now heads to the Texas House for approval. At the same time, the Texas Senate is cracking down on abortion pills. Other states making abortion news include North Carolina, Oklahoma, and Tennessee.
The chemical additive has been used to prevent tooth decay. The bill, which passed the state House on Tuesday, awaits Gov. Ron DeSantis' signature. Other news is about PBM regulations, sick leave, life expectancy trends, and more.
From 2011 to 2017, Gilead held dinners to promote its HIV medications at expensive restaurants that federal authorities claim were “wholly inappropriate” venues, Stat reported. Gilead said it settled to avoid the cost and distraction of potential litigation.
Roll Call reports that the 7-2 decision rejects an effort by hospitals for higher pay for serving low-income patients. Other Medicare and Medicaid news is on prior authorizations, Medicaid cuts, and more.
According to the nonpartisan Penn Wharton Budget Model, which tracks weekly Treasury data, total spending rose by 6.3%, or $156 billion, since Donald Trump took office, compared to the first four months of 2024, Politico reported.
FDA Chief Dr. Marty Makary said Tuesday that he'd "like to see some good data" on the vaccines before deciding whether to approve a new version later this year. Plus: Reuters reports that the CDC told the National Academy of Sciences to cancel a workshop on how to prevent human bird flu infections.
Today's early morning highlights from the major news organizations.
Opinion writers tackle these public health topics.
This is an increase of 300,000 cases from a year ago. At the same time, NIH funding cuts will stall research and harm Alzheimer's patients, USA TODAY reported. In other Alzheimer's news, improved diagnostic testing has up to 91% accuracy; new research shows it's common for patients with Alzheimer's to also have biomarkers for dementia; and more.
The law was set to be reinstated Wednesday but has been temporarily blocked by U.S. District Judge Anne Traum to allow Planned Parenthood time to challenge it. They have until Friday to file an appeal.
Simultaneously, a new Tebra survey found that 36% of GLP-1 users are microdosing, with 38% of those people citing the desire to save money.
© 2026 KFF